...
aztr-img

Azitra Inc, Common Stock

AZTR

ASQ

$0.525

+$0.01

(1.93%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.89M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.0055
Volume info-icon
This is the total number of shares traded during the most recent trading day.
79.25K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.43 L
$68.4 H
$0.525

About Azitra Inc, Common Stock

Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAZTRSectorS&P500
1-Week Return10.51%2.3%1.73%
1-Month Return-0.21%-1.77%3.44%
3-Month Return-26.33%-6.07%7.02%
6-Month Return-91.3%2.45%13.38%
1-Year Return-98.49%12.17%32.25%
3-Year Return8556.67%10.46%29.27%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue-110.00K284.00K686.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":16.03,"profit":true},{"date":"2022-12-31","value":41.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue-84.77K405.98K425.55K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":19.92,"profit":true},{"date":"2022-12-31","value":95.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit-25.23K(121.98K)260.45K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":9.69,"profit":true},{"date":"2022-12-31","value":-46.83,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin-22.93%(42.95%)37.97%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":60.41,"profit":true},{"date":"2022-12-31","value":-113.12,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses-9.33M9.74M8.30M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":95.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.26,"profit":true}]
Operating Income-(9.22M)(9.45M)(7.62M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-922145400,"profit":false},{"date":"2022-12-31","value":-945360400,"profit":false},{"date":"2023-12-31","value":-761639500,"profit":false}]
Total Non-Operating Income/Expense-223.57K(1.47M)(4.00M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-659.23,"profit":false},{"date":"2023-12-31","value":-1789.14,"profit":false}]
Pre-Tax Income-(8.94M)(10.68M)(11.27M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-893967500,"profit":false},{"date":"2022-12-31","value":-1068036600,"profit":false},{"date":"2023-12-31","value":-1126647300,"profit":false}]
Income Taxes-174.45K(727.80K)17.31K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-417.2,"profit":false},{"date":"2023-12-31","value":9.92,"profit":true}]
Income After Taxes-(9.11M)(9.95M)(11.28M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-911412500,"profit":false},{"date":"2022-12-31","value":-995256800,"profit":false},{"date":"2023-12-31","value":-1128378100,"profit":false}]
Income From Continuous Operations-(8.94M)(10.68M)(11.28M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-893967500,"profit":false},{"date":"2022-12-31","value":-1068036600,"profit":false},{"date":"2023-12-31","value":-1128378100,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income-(8.94M)(10.68M)(11.28M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-893967500,"profit":false},{"date":"2022-12-31","value":-1068036600,"profit":false},{"date":"2023-12-31","value":-1128378100,"profit":false}]
EPS (Diluted)---(13.09)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-1308.96,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AZTR
Cash Ratio 5.31
Current Ratio 5.58

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AZTR
ROA (LTM) -93.46%
ROE (LTM) -222.30%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AZTR
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AZTR
Trailing PE 0.01
Forward PE NM
P/S (TTM) 38.69
P/B 0.47
Price/FCF NM
EV/R 10.99
EV/Ebitda NM

FAQs

What is Azitra Inc share price today?

Azitra Inc (AZTR) share price today is $0.525

Can Indians buy Azitra Inc shares?

Yes, Indians can buy shares of Azitra Inc (AZTR) on Vested. To buy Azitra Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AZTR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Azitra Inc be purchased?

Yes, you can purchase fractional shares of Azitra Inc (AZTR) via the Vested app. You can start investing in Azitra Inc (AZTR) with a minimum investment of $1.

How to invest in Azitra Inc shares from India?

You can invest in shares of Azitra Inc (AZTR) via Vested in three simple steps:

  • Click on Sign Up or Invest in AZTR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Azitra Inc shares
What is Azitra Inc 52-week high and low stock price?

The 52-week high price of Azitra Inc (AZTR) is $68.4. The 52-week low price of Azitra Inc (AZTR) is $0.43.

What is Azitra Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Azitra Inc (AZTR) is 0.0055

What is Azitra Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Azitra Inc (AZTR) is 0.47

What is Azitra Inc dividend yield?

The dividend yield of Azitra Inc (AZTR) is 0.00%

What is the Market Cap of Azitra Inc?

The market capitalization of Azitra Inc (AZTR) is $3.89M

What is Azitra Inc’s stock symbol?

The stock symbol (or ticker) of Azitra Inc is AZTR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top